Selected article for: "active infection and acute sars cov respiratory syndrome coronavirus"
Author: Roni Ben-Ami; Agnes Klochendler; Matan Seidel; Tal Sido; Ori Gurel-Gurevich; Moran Yassour; Eran Meshorer; Gil Benedek; Irit Fogel; Esther Oiknine-Djian; Asaf Gertler; Zeev Rotstein; Bruno Lavi; Yuval Dor; Dana G Wolf; Maayan Salton; Yotam Drier
Title: Pooled RNA extraction and PCR assay for efficient SARS-CoV-2 detection
  • Document date: 2020_4_22
    • ID: 5s03f0pp_1
    Snippet: An emerging novel severe acute respiratory syndrome-related coronavirus, SARS-CoV-2, is the virus behind the global COVID-19 pandemic. Among the foremost priorities to facilitate efficient public health interventions is a reliable and accessible diagnosis of an active SARS-CoV-2 infection. The standard laboratory diagnosis of COVID-19 involves three main steps, namely, viral inactivation and lysis of the nasopharyngeal swab sample, extraction (or.....
    Document: An emerging novel severe acute respiratory syndrome-related coronavirus, SARS-CoV-2, is the virus behind the global COVID-19 pandemic. Among the foremost priorities to facilitate efficient public health interventions is a reliable and accessible diagnosis of an active SARS-CoV-2 infection. The standard laboratory diagnosis of COVID-19 involves three main steps, namely, viral inactivation and lysis of the nasopharyngeal swab sample, extraction (or purification) of viral RNA, and reverse transcription (RT)-PCR. Due to the rapid spread of the virus and the increasing demand for tests, the limited availability of test reagents, mainly RNA extraction kits, has become (and is likely to continue to be) a major bottleneck as the pandemic expands.

    Search related documents:
    Co phrase search for related documents
    • accessible reliable diagnosis and public health: 1
    • accessible reliable diagnosis and transcription reverse: 1, 2
    • active SARS infection and global pandemic: 1, 2, 3, 4, 5, 6
    • active SARS infection and limited availability: 1
    • active SARS infection and major bottleneck: 1, 2
    • active SARS infection and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • active SARS infection and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • active SARS infection and swab sample: 1
    • active SARS infection and transcription reverse: 1, 2, 3, 4, 5
    • acute respiratory SARS syndrome relate coronavirus and public health: 1
    • acute respiratory SARS syndrome relate coronavirus and respiratory SARS syndrome relate coronavirus: 1, 2, 3
    • acute respiratory SARS syndrome relate coronavirus and SARS infection: 1
    • acute respiratory SARS syndrome relate coronavirus and SARS syndrome relate coronavirus: 1, 2, 3
    • acute respiratory SARS syndrome relate coronavirus and syndrome relate: 1
    • acute respiratory SARS syndrome relate coronavirus and syndrome relate coronavirus: 1, 2, 3